High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma
Open Access
- 10 March 2020
- Vol. 12 (3), 644
- https://doi.org/10.3390/cancers12030644
Abstract
Ewing sarcoma (EwS) is an aggressive cancer displaying an undifferentiated small-round-cell histomorphology that can be easily confused with a broad spectrum of differential diagnoses. Using comparative transcriptomics and immunohistochemistry (IHC), we previously identified BCL11B and GLG1 as potential specific auxiliary IHC markers for EWSR1-FLI1-positive EwS. Herein, we aimed at validating the specificity of both markers in a far larger and independent cohort of EwS (including EWSR1-ERG-positive cases) and differential diagnoses. Furthermore, we evaluated their intra-tumoral expression heterogeneity. Thus, we stained tissue microarrays from 133 molecularly confirmed EwS cases and 320 samples from morphological mimics, as well as a series of patient-derived xenograft (PDX) models for BCL11B, GLG1, and CD99, and systematically assessed the immunoreactivity and optimal cut-offs for each marker. These analyses demonstrated that high BCL11B and/or GLG1 immunoreactivity in CD99-positive cases had a specificity of 97.5% and an accuracy of 87.4% for diagnosing EwS solely by IHC, and that the markers were expressed by EWSR1-ERG-positive EwS. Only little intra-tumoral heterogeneity in immunoreactivity was observed for differential diagnoses. These results indicate that BCL11B and GLG1 may help as specific auxiliary IHC markers in diagnosing EwS in conjunction with CD99, especially if confirmatory molecular diagnostics are not available.Funding Information
- Deutsche Krebshilfe (DKH-70112257)
- Deutsche Forschungsgemeinschaft (DFG 391665916)
This publication has 73 references indexed in Scilit:
- BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing SarcomaPLOS ONE, 2013
- Molecular Diagnosis of Ewing Sarcoma Family of TumorsDiagnostic Molecular Pathology, 2009
- Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical supportVirchows Archiv, 2009
- Microsatellites as EWS/FLI response elements in Ewing's sarcomaProceedings of the National Academy of Sciences of the United States of America, 2008
- Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2008
- Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEVThe Journal of Molecular Diagnostics, 2007
- Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma CellsCancer Research, 2006
- Assignment of the GLG1 Gene for MG-160, a Fibroblast Growth Factor and E-Selectin Binding Membrane Sialoglycoprotein of the Golgi Apparatus, to Chromosome 16q22-q23 by Fluorescence in Situ HybridizationGenomics, 1995
- Reverse Transcriptase PCR Amplification of EWS/FLI-1 Fusion Transcripts as a Diagnostic Test for Peripheral Primitive Neuroectodermal Tumors of ChildhoodDiagnostic Molecular Pathology, 1993